Reducing Clostridioides difficile Infections in a Medical Intensive Care Unit: A Multimodal Quality Improvement Initiative.
dc.contributor.author | Barker, Lisa | |
dc.contributor.author | Gilstrap, Daniel | |
dc.contributor.author | Sova, Christopher | |
dc.contributor.author | Smith, Becky A | |
dc.contributor.author | Reynolds, Staci S | |
dc.date.accessioned | 2024-06-23T13:01:51Z | |
dc.date.available | 2024-06-23T13:01:51Z | |
dc.date.issued | 2024-07 | |
dc.description.abstract | BackgroundClostridioides difficile (C. diff) infection causes significant morbidity for hospitalized patients. A large medical intensive care unit had an increase in C. diff infection rates.ObjectivesThe aim of this project was to reduce the C. diff polymerase chain reaction (PCR) test positivity rate and the rate of C. diff PCR tests ordered. Rates were compared between preintervention (July 2017 to December 2019) and postintervention (January 2021 to December 2022) timeframes.MethodsUnit leadership led a robust quality improvement project, including use of quality improvement tools such as A3, Gemba walks, and plan-do-study-act cycles. Interventions were tailored to the barriers identified, including standardization of in-room supply carts; use of single-packaged oral care kits; new enteric precautions signage; education to staff, providers, and visitors; scripting for patients and visitors; and use of a C. diff testing algorithm. Statistical process control charts were used to assess for improvements.ResultsThe average rate of C. diff PCR test positivity decreased from 34.9 PCR positive tests per 10 000 patient days to 12.3 in the postintervention period, a 66% reduction. The average rate of PCR tests ordered was 28 per 1000 patient days in the preintervention period; this decreased 44% to 15.7 in the postintervention period.DiscussionWe found clinically significant improvements in the rate of C. diff infection and PCR tests ordered as a result of implementing tailored interventions in a large medical intensive care unit. Other units should consider using robust quality improvement methods and tools to conduct similar initiatives to reduce patient harm and improve care and outcomes. | |
dc.identifier | 00003465-202407000-00008 | |
dc.identifier.issn | 0730-4625 | |
dc.identifier.issn | 1538-8646 | |
dc.identifier.uri | ||
dc.language | eng | |
dc.publisher | Ovid Technologies (Wolters Kluwer Health) | |
dc.relation.ispartof | Dimensions of critical care nursing : DCCN | |
dc.relation.isversionof | 10.1097/dcc.0000000000000644 | |
dc.rights.uri | ||
dc.subject | Humans | |
dc.subject | Clostridium Infections | |
dc.subject | Cross Infection | |
dc.subject | Polymerase Chain Reaction | |
dc.subject | Infection Control | |
dc.subject | Intensive Care Units | |
dc.subject | Quality Improvement | |
dc.subject | Clostridioides difficile | |
dc.title | Reducing Clostridioides difficile Infections in a Medical Intensive Care Unit: A Multimodal Quality Improvement Initiative. | |
dc.type | Journal article | |
duke.contributor.orcid | Reynolds, Staci S|0000-0002-0366-1328 | |
pubs.begin-page | 212 | |
pubs.end-page | 216 | |
pubs.issue | 4 | |
pubs.organisational-group | Duke | |
pubs.organisational-group | School of Medicine | |
pubs.organisational-group | School of Nursing | |
pubs.organisational-group | Clinical Science Departments | |
pubs.organisational-group | Medicine | |
pubs.organisational-group | Medicine, Pulmonary, Allergy, and Critical Care Medicine | |
pubs.publication-status | Accepted | |
pubs.volume | 43 |
Files
Original bundle
- Name:
- Barker et al. Cdiff MICU_2024.pdf
- Size:
- 353.9 KB
- Format:
- Adobe Portable Document Format